During Shanghai Visit PhRMA Chairman Calls For Regulatory Systems To Support Innovation

During a three-day visit in Shanghai, PhRMA Chairman Robert Hugin met local stakeholders and outlined the organization’s advocacy priorities in China amidst the evolving Drug Administration Law.

SHANGHAI – Pharmaceutical Research and Manufacturers of America Chairman Robert Hugin is spending a week in China to meet stakeholders and highlight the organization’s goal to help develop a thriving R&D infrastructure in the country.

It is the third year in which a PhRMA chairman has made the trip to China, but the first Shanghai...

More from China

More from Asia